Serum Collection Study for Assay Development
Trial statusRecruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age18-69
SponsorGPN Vaccines
About this trial
The study will collect serum from 12 participants vaccinated with Gamma-PN to assist with assay development and validation
Eligibility criteria
This trial accepts healthy volunteersQualifiers
good general health
Disqualifiers
no previous pneumococcal vaccine
Trial design
Design model
Single group
Treatments tested in this trial
Gamma-PN
Biological/VaccineKilled whole-cell pneumococcal vaccine
Treatment groups
12 Participants
are divided into 1 treatment groupGroup A: Gamma -PNExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
OPA
Opsonophagocytic assay
Time frame
6 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov